PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 64: Articles 31501-32000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Oral contraceptives and malignant hepatic tumours. (Letter to the editor)
  2. Oral contraceptives and malignant hepatoma. (Letter to the editor)
  3. Oral contraceptives and malignant hepatoma. (Letter to the editor)
  4. Oral contraceptives and myocardial infarction: report of three cases and review of the literature.
  5. Oral contraceptives and nutrition.
  6. Oral contraceptives and pulse rate.
  7. Oral contraceptives and reduced risk of benign breast diseases.
  8. Oral contraceptives and the red blood cell.
  9. Oral contraceptives and the thyroid gland. [Oralnie kontratseptivi i shitovidnaya zheleza.]
  10. Oral contraceptives and thromboembolism. [Letter]
  11. Oral contraceptives and thromboembolism. [Letter]
  12. Oral contraceptives and thromboembolism. [Letter]
  13. Oral contraceptives and thromboembolism. [Letter]
  14. Oral contraceptives and thromboembolism. [Letter]
  15. Oral contraceptives and thromboembolism. [Letter]
  16. Oral contraceptives and thromboembolism. [Letter]
  17. Oral contraceptives and thromboembolism. [Letter]
  18. Oral contraceptives from a neurological viewpoint. [Die Ovulationshemmer aus neurologischer Sicht.]
  19. Oral contraceptives in prophylaxis of acute exacerbations of intermittent porphyria. [Orale Knotrazeptiva zur Prophlylaxe akuter Schuebe der intermittierenden Porphyrie.]
  20. Oral contraceptives with lower hormonal doses. [P-piller med lavere hormondose.]
  21. Oral contraceptives, antithrombin-3 activity, and postoperative deep-vein thrombosis.
  22. Oral contraceptives, hypertension and nephrosclerosis. [Ovulationshemmer, Hypertonie und Nephrosklerose.]
  23. Oral contraceptives, norethindrone and mestranol: effects on tissue levels of minerals.
  24. Oral contraceptives, pregnancy, and the leukocyte count.
  25. Oral contraceptives.
  26. Oral contraceptives. [Les contraceptifs oraux.]
  27. Oral contraceptives. [Orale Kontrazeptiva.]
  28. Oral contraceptives: a guide from programs and clinics. 2nd ed.
  29. Oral contraceptives: how best to explain their effects to patients.
  30. Oral contraceptives: women's rights, nurses' responsibilities.
  31. Oral mucosal changes during pregnancy and hormonal contraception. [Veranderungen der Mundschleimhaut wahrend Schwangerschaft und kontrazeptiver Hormonbehandlung.]
  32. An oral progestogen as a coital contraceptive: experimental clinical study.
  33. Oral pyogenic granuloma as a complication of pregnancy and the use of hormonal contraceptives.
  34. Oral-contraceptive-induced hypertension after adrenalectomy and hypophysectomy.
  35. Ordinance No. 403 of 30 May 1975 on quality control of contraceptives.
  36. Organisation of family planning in occupational health services.
  37. Organisational problems of motivation in family planning.
  38. Organization of the wide use of intrauterine contraceptive agents. [K voprosu organizatsii shirokovo primeneniya vnutrimatochnykh protivozachatochnykh sredstv.]
  39. An organizational analysis of INPROMI with recommendations for family planning.
  40. Organizational issues in extending Comilla model to the national programme with references to family planning.
  41. Organizational problems of motivation in family planning.
  42. Organized family planning services in the United States: FY 1975.
  43. Organizing community resources in sexuality counseling and family planning for the retarded: a community worker's manual.
  44. Orientation of senior nursing students toward access to contraceptives.
  45. The outcome of pregnancy in former oral contraceptive users.
  46. Overcoming obstacles to contraception. [Vaincre les obstacles a la contraception.]
  47. Overview: 1975-contraceptive services of the family planning programs of IPPF in the western hemisphere. [Servicios anticonceptivos de Los programas de planificacion fam.]
  48. Overview: pulmonary embolism mortality in relation to oral contraceptive use.
  49. Ovulation method of birth control.
  50. The ovulation method of contraception.
  51. Panamanian journalists discuss population and family planning.
  52. Participative style of management in a family planning program.
  53. Patentex oval for contraception. ["Patentex oval" zur Kontrazeption.]
  54. Pathology of the hormonal contraceptive agents (Editorial) [La patologia dei mezzi contraccettivi ormonali.]
  55. Patient motivation in selection and acceptance of contraceptives.
  56. The pattern of acceptance by blacks of family planning facilities in relation to socio-economic status.
  57. Patterns of contraceptive acceptance after abortion: a study in four Asian hospitals.
  58. Pelvic inflammatory disease and intrauterine contraceptive devices. (Letter to the editor)
  59. Periodic world compilation and report on information on MCH and family planning.
  60. Permanent contraception: male and female sterilisation.
  61. Perspectives of intrauterine contraception. [Perspektive intrauterine kontracepcije.]
  62. Pharmacologic methods in family planning.
  63. Pharmacologic vigilance and oral contraceptives. [Pharmacovigilance et contraceptifs oraux.]
  64. The pharmacological properties of steroid contraceptives: review of literature. [Farmakoligicheskie svoistva steroidnikh kontratseptivnikh sredstv.]
  65. Philippine family planning acceptors' attitudes toward clinics.
  66. The philosophy of family planning.
  67. Pituitary-ovarian function following withdrawal of oral contraceptives in perimenopausal women.
  68. Place of IUD in the contraception-kit of India.
  69. Planned Parenthood in Bulgaria.
  70. Planning model for the delivery of family planning services in Los Angeles County.
  71. Planning or prevention? The new face of Family Planning.
  72. Planning principles for community education in family planning.
  73. Plasminogen activators in the endometrium of women using intrauterine contraceptive devices.
  74. Polish intrauterine contraceptive devices. [Polskie antykoncepcyjne wkladki wewnatrzmaciczne.]
  75. Poor acceptability of "pill-a-month" contraceptive: high pregnancy and drop-out rates in a small sample.
  76. Popland: a family planning client record data system. Unit 1. Design of the data system.
  77. Popular and traditional methods of contraception. [Methodes populaires et traditionnelles de contraception.]
  78. Population and family planning programs: a factbook.
  79. Possible carcinogenic hazards of oral contraception.
  80. Post-coital contraceptive effects of an agonistic analogue of luteinizing hormone releasing hormone.
  81. Post-contraceptive steroidal fertility: 14-year follow-up report.
  82. Postabortal use of oral contraceptives.
  83. Postcoital contraception [letter]
  84. Postcoital contraception.
  85. Postcoital contraception.
  86. Postpartum and postabortal use of injectable contraceptives.
  87. Postpartum contraception: subsequent pregnancy, delivery and abortion rates.
  88. Potencies of oral contraceptives.
  89. Practical measures for pregnancies following treatment with oral contraceptives. [Praktisches Vorgehen bei Schwangerschaften nach Ovulationshemmern.]
  90. Practicalities of family planning.
  91. Predicting effectiveness of contraception: a behavioral model for married couples.
  92. A prediction model of the current use of contraception in Belgium. [Een predictiemodel van het huidig anticonceptiegebruik in Belgie.]
  93. Pregnancies and combined oral contraceptives. [Grossesses et estroprogestatifs.]
  94. Pregnancy after oral contraception.
  95. Pregnancy and fetal outcome after cessation of oral contraceptives. [Schwangerschaftsverlauf und Zustand der Kinder nach Anwendung von Ovulat ionshemmern.]
  96. Pregnancy counseling and abortion referral for patients in federally funded family planning programs.
  97. Pregnancy in the presence of intrauterine contraceptive loop in the uterine cavity (author's transl) [Bremenmost pri nalichen v matochnata kykhina intrauterinen antikontseptsionen pesat(ivap)]
  98. Preliminary results from a Swedish multicenter trial of a new low dose combined oral contraceptive.
  99. Preliminary trials of an oral contraceptive for men. [Premiers essais d'une contraception chimique par voie orale chez h'homme.]
  100. Premarital sexual permissiveness and contraceptive knowledge: a biracial comparison of college students.
  101. The prescription of oral contraceptives is essentially a medical act. [La precription des anticonceptionnels oraux est essentiellement un acte medicale.]
  102. Present situation of family planning MCH programs.
  103. Present state of male contraception. [Etat actuel de la contraception masculine.]
  104. Prevention and treatment of the secondary effects of oral contraceptives using Citro B-6. [Prevention et traitement des effects secondaires des contraceptifs oraux par citro B6.]
  105. Prevention of cancer in women by contraception. [Prevention des cancers genitaux de la femme grace a la contraception.]
  106. Primary ovarian pregnancy and the intrauterine contraceptive device.
  107. Primary vascular pulmonary-hypertension and oral contraception. [Primar vaskulare pulmonale Hypertonie und Ovulationshemmer.]
  108. The problem of contraception among adolescents. [Le probleme de la contraception chez les adolescents.]
  109. Problem of family planning in women in the textile industry, an analysis of indications for pregnancy interruption. [Zagadnienie planowania rodziny w srodowisku wlokniarek z uwzglednieniem analizy spolecznych wskazan do przerwania ciazy.]
  110. Problems and approaches in communicating family planning to factory workers.
  111. Problems in implementing family planning programme in Karnataka: a study of medical, para-medical personnel and local leaders.
  112. Problems of contraception and family planning. [Probleme der Schwangerschaftsverhutung und Familienplanung.]
  113. Proceedings of the Expert Meeting on Comparative Fertility Research Sterilization and Post-Contraceptive Regulation, Kuala Lumpur, Malaysia, January 12-13, 1976.
  114. A profile of family planning clients at the family health clinic, Lagos, Nigeria.
  115. Progestasert - a new intrauterine contraceptive device.
  116. The Progestasert: intrauterine progesterone contraceptive system: release rated 65 mcg/day progesterone for one year.
  117. Progestational agents and blood coagulation: 7. Thromboembolic and other complications of oral contraceptive therapy in relationship to pretreatment levels of blood coagulation factors: summary report of a ten-year study.
  118. Progestational potency of oral contraceptives.
  119. Progesterone-releasing intrauterine contraceptive device.
  120. Program data for evaluation of family planning programs. Paper presented at the Caribbean Evaluation Workshop, International Planned Parenthood Federation/Western Hemisphere Region, Guadeloupe, French West Indies, June 21-27, 1976.
  121. Program for the integration of family planning & parasite control.
  122. Program of mobilization of community resources for family planning, Rio Grande do Norte, Brazil.
  123. Proposals of the Family Planning Division for family planning sector during the Fourth Five Year Plan (1970-75)
  124. Prospective long-term study of women on different contraceptives.
  125. The prospects for new, reversible male contraceptives.
  126. The protein antigens of human placenta as a basis for the development of contraceptive vaccine.
  127. Provision of maternal and child health services as a basis of motivation for family planning: an empirical investigation through record linkage.
  128. Provisional data from the National Reporting System for Family Planning Services, October-December 1975.
  129. Provisional data from the National Reporting System for Family Planning Services: January 1975-December 1975.
  130. Pruritus of pregnancy and jaundice induced by oral contraceptives.
  131. Psychiatric aspects of oral contraceptive use.
  132. Psychic acceptance of surgical contraception by men and women. [Die seelische Verarbeitung der chirurgischen Kontrazeption bei Mann und Frau.]
  133. Psycho-socio-biological studies of human fertility in Mexico: 2. Attitudes, knowledge and practice of contraception in Mexico: a summary. (Press release)
  134. Psychobiological studies of human fertility in Mexico. 1. Educational aspects of the university family planning campaign. [Estudios psicobiologicos de la fertilidad humana en Mexico. 1. Aspectos educativos de la campana universitaria de planificacion familiar.]
  135. Psychodiagnostic follow-up of Neovletta - a new low dose oral contraceptive.
  136. Psychological and sexual aspects of contraception in adolescents. [Aspect psychologiques et sexologiques de la contraception chez l'adolescente.]
  137. Psychological aspects of contraception.
  138. Psychological aspects of family planning. [Aspectos psicologicos de la planeacion familiar.]
  139. Psychological aspects of surgical contraception.
  140. Psychological correlates of family size, son preference, and birth control in Taiwan.
  141. Psychological correlates of the menstrual cycle and oral contraceptive medication.
  142. Psychological results of tubal ligation as a definitive method of contraception. [Die psychische Verabeitung der Tubensterilisation als definitive Kontraz eptionsmethode.]
  143. Psychological-sociological aspects of oral contraceptives. Results of an empirical study in 345 women. [Ovulationshemmer-Nebenwirkungen unter psychologisch-soziologischen Aspekten. Ergebnisse einer empirischen Untersuchung an 345 Frauen.]
  144. Psychometric testing as a basis for counseling patients choosing a method of contraception; a retrospective study.
  145. The psychosocial acceptability of contraceptive technology.
  146. Psychotropic action of oral contraceptives.
  147. Pulmonary hypertension and oral contraceptive usage. (Editorial)
  148. Pulmonary hypertension in patients using oral contraceptives: a report of six cases.
  149. Pulmonary side effects of oral contraceptives. [Pulmonale Nebenerscheinungen kontrazeptiver Steroide.]
  150. Quality of care given to first time birth control patients at a free clinic.
  151. A quantitative study of the pregnancy zone protein in sera of women taking oral contraceptives.
  152. A quarter of a century in natural family planning.
  153. The quest for a contraceptive method for the regulation of ovum transport.
  154. A radioimmunoassay for norethindrone: 2. Plasma levels in hypertensive and normotensive oral contraceptive users.
  155. The radiology of the intrauterine contraceptive device.
  156. Rarely noted aspects of hormonal contraception. [Zur Beruecksichtigung wenig beachteter Aspekte bei der Anwendung der hormonalen Kontrazeption.]
  157. Rates of acceptance, continuation, pregnancy, and contraceptive use; a comparison of sources of family planning services.
  158. Rationale for integrating family planning into rural and community development programmes.
  159. Raynaud's disease and the oral contraceptive pill. (Letter to the editor.)
  160. Real and apparent side effects of oral contraceptives with an emphasis on medical and hematological problems. Review of literature. [Scheinbare und wirkliche Nebenwirkungen der oralen Kontrazeptiva aus int ernistischhamatologischer Sicht. Eine kritische Wurdigung der Literatur.]
  161. Recent experiences on the ophthalmologic complications of oral contraceptives.
  162. The record of family planning programs.

     

  163. Rectouterine fistula associated with the Cu-7 intrauterine contraceptive device.
  164. Reducing fertility through beyond family planning measures.
  165. Regression of focal nodular hyperplasia after discontinuance of oral contraceptives. (Letter)
  166. Relations between oral contraception, vaginal candida and skin reaction to candidine. [Relations entre contraception orale, candidoses vulvovaginales et reactions cutanees a la candidine.]
  167. The relationship between oral contraceptives and adolescent sexual behavior.
  168. Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole.
  169. Relationships between cigarette smoking, oral contraceptives, and plasma Vitamins A, E, C, and plasma triglycerides and cholesterol.
  170. Removing oral contraceptives off prescription in Australia.
  171. Renal blood flow and its response to angiotensin: 2. an interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women.
  172. Renal thrombotic microangiopathy with benign hypertension and uremia secondary to oral contraceptives. [Renale thrombotische Mikroangiopathie mit benigner Hypertonie and Uraemie nach knotrazeptiver Hormontherapie.]
  173. Report of fertility & family planning survey of Kotala Village, Chandragiri Taluk, Chittoor District, Andhra Pradesh, India.
  174. Report of Fertility and Family Planning Survey of Tirupati town, Andhra Pradesh, India.
  175. Report of the 3rd meeting of the IPPF Law and Planned Parenthood Panel, London, April 26-27, 1976.
  176. Report of the evaluation team on the Morocco Family Planning Program.
  177. Report of the meeting of experts in natural family planning, Task Force on Methods for the Determination of the Fertile Period, Geneva, 9-11 February 1976.
  178. Report of the multinational study in methodologies for setting family planning targets in the ESCAP region.
  179. Report of the regional seminar on the role of surveys and studies for family planning programme management and development.
  180. Report of the Task Force II on research inventory and analysis of family planning communication research in Bangladesh.
  181. Report of the technical task force evaluation of regional project "continuing education program in administration of family planning programs."
  182. Report on 2nd Seminar on Population and Family Planning Education, Holte, Denmark, June 22-July 19, 1975.
  183. A report on a contraceptive social marketing experiment in rural Kenya.
  184. Report on consultation to the Family Planning and Population Program, Government of Tunisia.
  185. Report on pre-testing of the motivation kit for use in the project family planning communication development and integrated campaigns.
  186. A report on the utilization of videotape in the UAR Family Planning Program.
  187. Republic of Korea: population and family planning in Korea.
  188. A research-based system for improving information-education-communication programs for family planning in combination with community-based contraceptive distribution.
  189. Resivit and circulatory pathology of oral contraception. [Resivit et pathologie circulatoire de la contraception orale.]
  190. Resolving the "public health dilemma' of steroid contraception and its effects on lactation.
  191. Response to a document entitled "Effectiveness of Natural Family Planning Methods: a Preliminary Analysis of a Sub-sample of Clients of a Metropolitan Teaching Hospital".
  192. Response to a document entitled: "Family Planning, Ethics and Professional Responsibility: Some Observations from an Ongoing Nationwide Evaluation of Family Planning Clinics. Working Paper No. 2: Family Planning Evaluation Project, St. Vincent's Hospital, Sydney.
  193. Results of cytological and histological studies of the cervixuteri following long-term hormone contraceptive use. [Ergebnisse zytologischer und histologischer Untersuchungen der Cervix uteri nach langerer Einnahme hormonaler Kontrazeptiva.]
  194. Results of the prolonged use of a low-dose contraceptive pill in diabetics and "high-risk" women. [Resultats de l'utilisation prolongee d'un estroprogestatif faiblement dose chez des diabetiques et des femmes a ''haut risque.''.]
  195. Retinal damage and oral contraceptives. [Retinaskader og orale kontraceptiva.]
  196. A retrospective survey of over 1,000 patients on oral contraceptives in a group practice.
  197. A review of international clinical experience with a low-estrogen oral contraceptive. [Uebersicht internationaler klinischer Erfahrungen mit einem oestrogen-niedrig-dosierten oralen Kontrazeptivum.]
  198. A review of the association between oral contraceptives and breast diseases.
  199. A review of the effects of hormonal contraception on thyroid function. [Revue des effets de la contraception hormonale sur la foction thyroidienne.]
  200. Revised estimates of indices of contraceptive effectiveness and effective protection based on 1974 NAS data.
  201. Rheumatoid factor (antigammaglobulin) in women: effects of oral contraceptive use on its prevalence.
  202. Rhythm method of contraception.
  203. Rifampin, oral contraceptives, and pregnancy.
  204. (Risk of liver adenomas with ME-containing oral contraceptives) (Letter to the editor)
  205. The risk of pelvic inflammatory disease in women using intrauterine contraceptives devices as compared to non-users.
  206. The role of communication in programs that extend beyond family planning.
  207. The role of education and communications in population/family-planning programs.
  208. Role of husbands in family planning.
  209. The role of induced abortion in the changing pattern of family planning in the Netherlands.
  210. The role of sex education in planned parenthood.
  211. Role of sympathetic nervous system in the mechanism of contraceptive action of intrauterine device. [Ob uchastii simpaticheskoi nervnoi sistemi v mekhanizme kontratseptivnovo deistviya vnutrimatochnovo sredstva.]
  212. The role of the Family Planning Association in Hong Kong's fertility decline.
  213. The role of the intrauterine device in contraceptive practice.
  214. The role of the marriage and family department in implementation of family planning in the GDR. [Die Rolle der Sektion ''Ehe und Familie'' bei der Durchsetzing der Familienplanung in der DDR.]
  215. The role of the midwife in contraception. [Le role de la sage-femme dans la contraception.]
  216. Round table no. 7: the chemical control of fertilization in animals and in men and chemical contraception in human medicine. [Table ronde No. 7: La maitrise chimique de la fecondation chez les anima ux et chez l'homme et La contraception chimique en medecine humaine.]
  217. Rubella antibody tests in family planning clinics.
  218. Rubella immunisation and contraception - a case for re-examining the policy of the Department of Health and Social Security.
  219. Salpingitis: a frequent response to intrauterine contraception.
  220. Sandlike sensation in eyes associated with hormonal contraceptives. [Sandgefuhl der Augen und hormonale Kontrazeptiva.]
  221. Screening oral contraceptive candidates: is the doctor dispensable?
  222. Secondary amenorrhoea and oral contraceptives.
  223. Selection and management of contraceptives in the adolescent patient.
  224. Self-prescription of oral contraceptives in Bogota, Colombia.
  225. Self-test for ovulation and its implications in family planning.
  226. Semi-annual report July 1-December 31, 1975: Contraceptive Distribution Project.
  227. Semiquantitative evaluation of the isotope nephrogram during continuous long-term treatment with contraceptive steroids. [Semiquantitative Auswertung der Isotopennephrogramme unter kontinuierlicher Langzeiteinnahme antikonzeptioneller Steroide.]
  228. Sequential birth control pills discontinued.
  229. Sequential oral contraceptives removed from the market.
  230. Sequential oral contraceptives.
  231. Serious adverse effects of oral contraceptives and estrogens.
  232. Serious complications of intrauterine contraception: two case reports. [Alvorlige komplikationer ved anvendelse af intrauterin kontraception: to kasuistikker.]
  233. Serum iron norms in women taking oral contraceptives.) (Abstract only. [Serum-Eisen-Normalwerte bei Frauen unter oralen Kontrazeptiva.]
  234. Serum levels of pregnancy-associated alpha2-glycoprotein during contraceptive treatment.
  235. Serum lipid changes during contraceptive administration in obese women: relation to serum insulin levels.
  236. Serum protein fractions: effects of oral contraceptives and pregnancy.
  237. Seven-year progress report on long-term oral contraceptive studies in female dogs and monkeys. (Abstract only)
  238. Several comments on the long-term use of hormonal contraceptives in family planning. [Nekolik poznamek k dlouhodobemu podavani hormonalni antikoncepce pri planovanem rodicovstvi.]
  239. Severe atypical endometrial changes and sequential contraceptive use.
  240. Sex and socialism: the opposition of the French left to birth control in the nineteenth century.
  241. Sex education and the national family planning programme.
  242. Sex, birth control, and human life.
  243. Sexual and contraceptive behavior in young unmarried women.
  244. Sexual experience, contraceptive usage, and source of contraception for never married women: Albany (NY) health region.
  245. Sexual function and contraception.
  246. Sexual problems in family planning.
  247. Sexual relationship and birth control in Ghana: a case study of a rural town.
  248. Sexually transmitted diseases and their relation to contraception.
  249. Should lactating mothers be given contraceptive pills, and if so which kind?
  250. Side effects and complications of oral contraception. [Incidents et accidents de la contraception orale.]
  251. Side effects of oral contraceptives. [O dzialaniu ubocznym doustnych srodkow antykoncepcyjnych.]
  252. Side reactions and complications with the use of hormonal contraceptives. [Pobochnie reaktsii i oslozhneniya pri primenenii gormonalnikh kontratseptivov.]
  253. Side-effect of oral contraceptives: occlusion of branch artery of the retina.
  254. Significance of low body weight in ovulatory dysfunction after stopping oral contraceptives.
  255. A simple method for the determination of free cortisol in plasma, with normal levels in men and women, including women taking low oestrogen contraceptives.
  256. Singapore family planning and population board family planning telephone information service: a review of twenty-two months experience.
  257. Small bowel perforation by a shield type intrauterine contraceptive device.
  258. Smoking and oral contraceptives. [Tabagisme et contraceptifs oraux.]
  259. Social and psychological aspects of contraception for adolescents. [Les aspects sociaux et psychologiques de la contraception chez l'adolescente.]
  260. Social aspect of family planning.
  261. Social class, working women and contraception. [Soziale Schicht, Frauenarbeit und Kontrazeption.]
  262. Social welfare and family planning.
  263. Social, psychological and sexological aspects of oral contraception. [Aspectos sociales, psicologicos y sexologicos de la contracepcion oral.]
  264. Socio-economic factors affecting contraception.
  265. Socio-legal considerations and family planning programmes in Africa.
  266. Socioeconomic factors in family planning.
  267. Sociological and psychological aspects of adolescent contraception. [Aspectos sociologicos y sicologicos de la anticoncepcion en anticoncepcion en adolescentes.]
  268. Some areas of the law relevant to family planning in medical practice: an analysis from a comparative perspective.
  269. Some aspects of contraception in 1975. [Quelques aspects de la contraception en 1975.]
  270. Some aspects of family planning in a defined urban population of Jammu (Kashmir)
  271. Some attitudes (about birth control, abortion, and sterilization)
  272. Some bioethical dimensions of distributing oral contraceptives through non-clinical settings in developing countries.
  273. Some characteristics of ever-married ever-pregnant women < or = 49 years old in PGE sample areas who reported themselves as never ever having used any family planning method.
  274. Some effects of oral contraceptives on vitamins and on carbohydrate and lipid metabolism.
  275. Some ethical issues in family planning.
  276. Some factors reflecting the condition of the internal uterine medium in intrauterine contraception. [Nekotorye pokazateli sostoyaniya vnutrennei sredy matki pri vnutrimatochnoi kontratseptsii.]
  277. Some immune responses of Gambian women taking the combined oral contraceptive pill.
  278. Some reflections on male reproductive biology and contraception.
  279. Some reflections on national family planning programs.
  280. Some reflections on the opportunity cost of national family planning programs.
  281. Some suggested improvements to current statistical methods of analyzing contraceptive efficacy.
  282. Some traditional and modern media for communicating developmental ideas in Africa: a case study of communication of family planning in Ghana.
  283. Sonographic localization of intra-uterine contraceptive devices. (Abstract only)
  284. Specific changes in the cervix related to oral contraceptives. [Ueber durch Ovulationshemmer verursachte spezifische Veraenderungen der Cervix uteri.]
  285. Specific increase in a high density lipoprotein subfraction in women using birth control pills. (Abstract only)
  286. Spinal cord ischemia after oral contraception for seven years. [Spinale Durchblutungsstorungen, Syndrom der arteria Sulcocommissuralis, nach langjahriger Ovulationshemmereinnahme.]
  287. Spontaneous expulsion of contraceptive spiral during the 31stweek of gestation. [Samoistne wypadniecie spirali antykoncepcyjnej w 31 tygodniu ciazy.]
  288. Spontaneous intrauterine rupture of contraceptive Lippes loop (author's transl) [Samoistne wewnatrzmaciczne pekniecie antykoncepcyjnej wkladki Lippesa.]
  289. Spontaneous rupture of liver in patient on oral contraceptives.
  290. Sri Lanka: family planning in the organized sector - the role of the Department of Labor, Sri Lanka.
  291. Stage method for multiple physiological hormone contraception. [Eine Stufenmethode fuer eine mehr physiologische hormonale Kontrazeption.]
  292. Stated expectations of use of family planning: how good a predictor of subsequent use?
  293. States fail to assume responsibility for administering family planning programs.
  294. Statistical norms for maternal-infant welfare and family planning in the mobile clinics. [Normes statistiques pour la protection materno-infantile et la planification familiale dans les cliniques mobiles.]
  295. Status of national population information system in the Republic of Korea: National Population Clearing House at the Korean Institute for Family Planning as a national coordinating unit.
  296. Status of women and family planning in India.
  297. Status of women and the knowledge, attitude and practice of family planning in Southwest Nigeria: an empirical investigation.
  298. The status of women in family planning.
  299. Sterilization as a method of contraception: results of consultations on desire for vasectomy. [Die Sterilisation als Methode der Antikonzeption: Ergebnisse von Beratungsgespraechen bei Wunsch nach Vasektomie.]
  300. Sterilization in family planning using the example of a counseling center - Hamburg. [Sterilisation in der familien-planung am Beispiel einer Beratungsstelle in Hamburg.]
  301. Sterilizations quadruple in India's intensified Family Planning program.
  302. Steroid contraceptive agents and immunological reactivity in experimental animals.
  303. Steroid contraceptives in non-human primates: 1. Metabolic fate of synthetic estrogens in the baboon before exposure to oral contraceptives.
  304. Steroid delivery systems for contraception.
  305. Steroidal implants for contraception.
  306. Stimulating demand for family planning: a proposal.
  307. A strategy for contraception.
  308. Stressing the natural in natural family planning.
  309. Strokes in young women caused by oral contraceptives. [Insultos vasculares causados en mujeres jovenes por anticonceptivos oral es.]
  310. Studies of the consequences of contraceptive failure: final report.
  311. Studies of the influence of some gestagens on the carbohydrate metabolism in women during oral contraceptive therapy. (Abstract only)
  312. Studies on aflatoxin B1 toxicity in female rats pretreated with an oral contraceptive agent.
  313. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha-ethynyl estradiol concentrations.
  314. A study of contraceptive use-effectiveness of the 75 mcg. ethinyl estradiol sequential therapy.
  315. Study of conventional contraceptive use, Gujarat, India.
  316. Study of conventional contraceptive users Gujarat, India.
  317. A study of family planning of low-income families in selected small towns of Louisiana.
  318. A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive.
  319. A study of managerial style of the district family planning administrators.
  320. Study of the action of oral contraceptives on folate blood levels. [Etude de l'action de contraceptifs oraux sur les taux sanguins des folates.]
  321. Study of the Dalkon shield by scanning electron microscope. [Contraceptifs innra-uterins. Etudes sur le Dalkon Shield par microscopie electronique a balayage. Intrauterine contraceptives.]
  322. A study of the knowledge, attitudes and beliefs of Malaysian youths on social and biological development. Preliminary report. Paper presented at the Seminar on Planning Family Life Education Programmes for Youth, Kuala Lumpur, Malaysia, March 26-28, 1976.
  323. A study of traditional and modern media for communicating family planning in Ghana.
  324. A study of women's attitudes and feelings about their experiences at family planning clinics and private gynecology offices.
  325. Study on contraceptive mechanism of copper and plastic intrauterine devices in rats (author's transl)
  326. Subsidized sales program: the Philippines Commercial Contraceptive Marketing Program.
  327. Suggested instructions for those using contraceptive methods.
  328. Summary minutes of the OTC panel on contraceptives and other vaginal drug products, twenty-eighth meeting, October 7 and 8, 1976, Parklawn Building, Rockville, Maryland.
  329. Summary minutes of the OTC Panel on Contraceptives and Other Vaginal Drug Products, twenty-fifth meeting, April 22 and 23, 1977, Parklawn Building, Conference Room M, Rockville, Maryland.
  330. Summary minutes of the OTC panel on contraceptives and other vaginal drug products, twenty-fourth meeting, February 26 and 27, 1976.
  331. Summary minutes of the OTC Panel on Contraceptives and Other Vaginal Drug Products, twenty-ninth meeting, November 19 and 20, 1976, Parklawn Building, Rockville, Maryland.
  332. Summary minutes of the OTC Panel on Contraceptives and Other Vaginal Drug Products, twenty-seventh meeting, August 24 and 25, 1976, Parklawn Building, Rockville, Maryland.
  333. Supplemental contraception.
  334. Supplemental contraception. (Letter to the editor)
  335. Supreme Court says minors don't need parental consent to get contraceptives in federally subsidized programs.
  336. Surgical contraception versus sterilization: Psychohygenic aspects of counseling for vasectomy and tubal ligation. [Chirurgische Kontrazeption versus Sterilisation. Psychohygienische Aspek te der Beratung vor Vasedtomie und Tubenligatur.]
  337. Surgical treatment of liver adenoma caused by contraceptive agents. [Anticoncipiens kezeles kapcsan letrejovo maj-adenoma operalt esete.]
  338. Survey of attitudes, knowledge and use of family planning methods among P.R. men living in low socio-economic neighborhoods.
  339. Survey of contraceptive laws: country profiles, checklists, and summaries.
  340. A survey of fertility and family planning of the nomadic population of Iran. [Une enquete sur la fecondite et le plan familial dans la population nomade d'Iran.]
  341. A survey of fertility histories and contraceptive use among a group of Navajo women.
  342. Sweden's way to sex education and birth control.
  343. Syndrome due to oestro-progestogens in a worker engaged in the production of an oral contraceptive. [Sindrome da estroprogestinici in operaio addetto alla produzione di un farmaco anticoncezionale.]
  344. Systemic contraceptives and liver tumors. (Editorial)
  345. Systemic side effects of oral contraceptive agents. (Doctoral dissertation, State University of New York, 1975)
  346. Taking on the tide. (Family planning in Asia)
  347. The teacher in family planning. [El maestro en la planificacion familiar.]
  348. Teachers training course in natural methods of family planning.
  349. Technology and strategy for expanding surgical family planning services.
  350. Teenage educational and medical contraceptive service in Washington, D.C.
  351. Thailand contraceptive marketing program: a comprehensive presentation of deep rural Thailand marketing and media program elements. Vol. 2. Prototype condom media/promotional program.
  352. Thoughts on the effects of the aging of human gametes as they relate to the use of natural family planning methods.
  353. Three and one-half years' experience with a lower-dose combination oral contraceptive.
  354. Thrombosis - perspective on a major side effect of oral contraceptives.
  355. Thrombosis - perspective on a major side effect of oral contraceptives. (Letter)
  356. Thrombosis - perspective on a major side effect of oral contraceptives. (Letter)
  357. Thrombosis - perspective on a major side effect of oral contraceptives. (Letter)
  358. Thrombosis - perspective on a major side effect of oral contraceptives. (Letter)
  359. Thrombosis resulting from oral contraception. [Les accidents thrombotiques de la methode contraceptive hormonale.]
  360. Thrombotic accidents in hormonal contraception. [Les accidents thrombotiques de la methode contraceptive hormonale.]
  361. Tracheo-oesophageal fistula associated with hormonal contraception during pregnancy.
  362. Traditional birth control methods in Yorubaland.
  363. The traditional midwife: can she be incorporated into a pilot maternal and child health and family planning program. [La partera empirica: colaboradora potencial del Programa Nacional de salud Maternoinfantil y Planificacion Familiar?]
  364. Training and institutional development for surgical family planning services.
  365. Translocation of intrauterine contraceptive device.
  366. Treatment of nausea and vomiting observed in some patients starting oral contraception. [Un nuevo enfoque terapeutico en el tratamiento de la nausea y vomito debidos al uso del anticonceptivos.]
  367. Treatment with combined oral contraceptives and myocardial infarction. [Traitement contraceptif oral par les oestroprogestatifs et infarctus du myocarde.]

     

  368. Trends in contraceptive practice: 1965-1973.
  369. Tumors of the liver and oral contraceptives.
  370. Tunisian legislation in family planning affairs. [Legislation Tunisienne en matiere de planning familial.]
  371. Tunisians and contraception. [Les tunisiennes et la contraception.]
  372. The twain never met: Sherupur, India, and the family planning program.
  373. Two modifications of the intrauterine membrane contraceptive device.
  374. Ultrastructure of liver cells in women using oral contraceptives. [L'ultrastructure du foie au cours de la prise de contraceptifs oraux.]
  375. The United States National Family Planning Program, 1968-74.
  376. The use of birth control.
  377. Use of contraception.
  378. Use of health auxiliary of CBFPS (Community Based Family Planning Services)
  379. The use of incentives in family planning programmes: a study of competing theories regarding their influence on attitude change.
  380. Use of KAP data for family planning programme management.
  381. Use of long-acting depot progestogen in domiciliary family planning.
  382. The uses and limits of current contraceptive technology.
  383. Using agricultural analogies to teach family planning.
  384. Uterine aspiration techniques in family planning.
  385. Utility of male and female investigators in surveys related to fertility and family planning - a pilot study.
  386. The utilization of conception cohorts for the evaluation of family planning programs.
  387. Utilization of public administration principles and practices in the training of family planning programme administrators.
  388. Variations in serum iron and total iron binding capacity with the time of intake of combined oral contraceptives.
  389. Variations of the enzyme inducing effects of contraceptive agents in different animal species.
  390. Various forms of contraception and the rising frequency of extrauterine pregnancy. [Enkele vormen van anticonceptie en de stijgende frequentie van extra-uteriene graviditeit.]
  391. Vas deferens contraceptive methodology.
  392. Vascular disease and oral contraceptives: familial hyperlipoproteinaemia as a predisposing factor.
  393. Vascular retinal complication after long-term therapy with hormonal contraceptives. [Vaskulare retinale Komplikation nach Langzeittherapie mit hormonalen Kontrazeptiva.]
  394. Vasectomy: a case study of planned parenthood clinic.
  395. Veno-occlusive disease of the liver associated with oral contraceptives: case report and review of literature.
  396. Vertebral artery occlusion and oral contraceptives.
  397. Vertigo in women using hormonal contraceptives. [W sprawie zawrotow glowy u kobiet przyjmujacych hormonalne srodki antykoncepcyjne.]
  398. Vigourously implemented family planning programs can cut birthrate prior to general socioeconomic development.
  399. Village and household availability of contraceptives: Southeast Asia, 1976.
  400. Village and household availability of contraceptives: the Taiwan experience.
  401. The village family planning post program (POS KB desa) of West Java province, Indonesia: a behavioral analysis.
  402. Village family planning: the Indonesian model: institutionalizing contraceptive practice.
  403. Village volunteers boost Thai family planning.
  404. Virucidal effect of certain chemical contraceptives on Type 2 herpesvirus.
  405. Visual apparatus and oral contraceptives. [Appareil visuel et contraceptifs oraux.]
  406. Vitamin B12 and folic acid in women taking oral contraceptives. [Vitamin B12 und Folsauere im Plasma unter der Einnahme von oralen Kontrazeptiva.]
  407. Vitamin B6 status of young men, women, and women using oral contraceptives.
  408. Vitamin supplements to women using oral contraceptives (studies of Vitamins B1, B2, B6 and A)
  409. The in vitro uptake of some oral contraceptive steroids by magnesium trisilicate.
  410. Voluntary interruption of pregnancy. A medical act, an occasion for information on contraception. [L'interruption volontaire de grossesse. Un acte medical, une occasion d'informer sur la contraception.]
  411. Voluntary sterilization in Tunisian family planning and health service programs: a national approach.
  412. Voluntary surgical contraception (draft) guidelines.
  413. What's new in contraception for adolescents?
  414. When should a woman aged over 50 leave off taking a low-estrogen oral contraceptive that is used mainly to control migraine attacks rather than for contraception? Are there any real dangers in continuing the dose for an indefinite period?
  415. Which birth control pill should be prescribed?
  416. Why family planning fails in poor countries.
  417. Why some family planning program fail.
  418. Wider non-medical distribution of oral contraceptives. (Letter to the editor)
  419. Women in Jakarta: family life and family planning.
  420. Women's modesty: one barrier to the use of family planning clinics in Ecuador.
  421. Women's organizations: a resource for family planning and development.
  422. Word usage in family planning.
  423. World study shows family planning programs reducing fertility in LDCs: one-quarter of married women enrolled.
  424. The world voluntary movement to promote surgical contraception.
  425. Two oral contraceptives with the same gestagen and different estrogen: a controlled clinical trial.
  426. Abortion or contraception? [Aborto o contraccezione?]
  427. Changes of natural fertility and contraceptive equivalents.
  428. Child health: a motivating force for family planning.
  429. A comparison of program and contraceptive use continuation rates in a family planning clinic.
  430. Ecuador. (Family planning programs)
  431. Emotional factors in family planning.
  432. Sexual activity and contraception use in young adults.
  433. Side effects of oral contraceptives. (Letter to the editor)
  434. The Family Planning Advisory Committee: a creative experience.
  435. Functional and post-oral contraceptive amenorrhoea: response to luteinizing hormone releasing hormone (LH-RH)
  436. History of hormonal contraception. [Zur Geschichte der hormonalen Empfangnisverhutung.]
  437. Hormonal contraception with microdoses of gestagens. [Gromonalnaya Kontracepciya mikrodozami gestagenov.]
  438. Hospital family planning: collecting information: a first step in monitoring the service.
  439. India. (Family planning programs)
  440. Influence of hormonal contraceptives on the incidence of urinary tract infections. [Einfluss hormonaler Kontrazeptiva auf die Haufigkeit von Harnwegsinfekti onen.]
  441. Influence of hormonal contraceptives on X-chromatin. [Zur Frage der Beeinflussung der X-Chromatinfrequenz durch hormonale Komtrazeptiva.]
  442. Kenya. (Family planning programs)
  443. Latin America 1974: an overview. (Family planning programs)
  444. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
  445. Morocco. (Family planning programs)
  446. Oral contraceptives in acute viral hepatitis.
  447. Philippines. (Family planning programs)
  448. The politics of birth control, 1920-1940: the impact of professionals.
  449. Predictors of contraceptive practice for low-income women in Cali, Colombia.
  450. Radioimmunologische Untersuchungen der gonadotropen Hormone im Serum unter hormonaler Kontrazeption. (Radioimmunological studies of serum gonadotropins during hormonal contraception.)
  451. Reliability estimates of some survey data on family planning.
  452. Some principles of cost-benefit analysis of family planning services in developing countries.
  453. Status of women as related to family planning.
  454. Venezuela. (Family planning programs)
  455. Vaginal contraceptives: a time for reappraisal?/Contraceptivos vaginais : e hora de reconsiderar?/Anticonceptivos vaginales : aun a tiempo de revaluarlos?
  456. Training nonphysicians in family planning services and a directory of training programs./O treinamento de nao medicos em servicos de planejamento da familia e indicador de programas de treinamento./Formation de non physiciens concernant des fonctions relevant du planning familial et repertoire de programmes de formation.
  457. Contraceptive distribution - taking supplies to villages and households./Distribuicao de anticoncepcionais em aldeias e domicilios./Distribution des contraceptifs; comment approvisioner les villages et les familles.
  458. Oral contraceptives: advantages of orals outweigh disadvantages./Avantages et inconienients des contraceptifs oraux : un bilan positif./Contraceptivos orais mais vantagens do que desvantagens./Las ventajas de los orales sobrepasan las desventajas.
  459. Advertising principles applicable to family planning information campaigns.
  460. Advice for contraception in adolescents.
  461. After Bucharest: approaches to the integration of family planning and development in Puerto Rico.
  462. After family planning - what?
  463. Age of first coitus and choice of contraceptive method: preliminary report on a study of factors related to cervical neoplasia.
  464. The agricultural approach in Philippine family planning communications.
  465. Aims and objectives for teaching of human reproduction, family planning and population dynamics in medical colleges.
  466. Alterations of lipid metabolism by contraceptive steroids.
  467. Alternative to hormonal contraception. [Die Alternative zue hormonalen Kontrazeption?]
  468. Amenorrhea due to oral contraceptives. [Ovulationshemmer-Amenorrhoe.]
  469. Amino acid constitution of the contraceptive polypeptide from hamster zygotes.
  470. An analysis of the reported association of oral contraceptives to thromboembolic disease.
  471. An analysis of the work site as a setting for family planning services to low income workers.
  472. Analytical assessment of the implementation systems for family planning programmes: frame of reference for national studies.
  473. An analytical study of implementation systems of national family planning programme in Indonesia.
  474. Ancient and modern: a brief history of contraception.
  475. Annotated bibliography on contraception in adolescence.
  476. Annual summary of family planning services, 1973.
  477. The antibaby pill: bases of hormonal contraception for the practitioner. [Die Antibaby-Pille: Grundlagen der hormonalen Kontrazeption fur den praktischen Arzt.]
  478. Antiepileptic drugs and the efficiency of oral contraceptives. [Antiepileptika und die Sicherheit oraler Kontrazeptiva.]
  479. Antiepileptic drugs and the safety of oral contraceptives. (Abstract only)
  480. Appendix: bibliography of Indian bibliographies on demographic research in population and family planning.
  481. Application of operations research techniques to a family planning programme: an approach to build management information systems.
  482. An approach to evaluation of the effectiveness of health aides in recruiting and maintaining clients on oral contraceptives.
  483. Area physician and family planning. [Bereichsarzt und Familienplanung.]
  484. The role of medical students and youths in family planning and population programme.
  485. The role of midwives and traditional birth attendants in maternal and child health and family planning in Malaysia.
  486. The role of midwives and traditional birth attendants in maternal and child health and family planning in Malaysia.
  487. The role of nurses and midwives in family planning.
  488. The role of nurses and midwives in family planning.
  489. The role of plural marriage in family planning policy.
  490. The role of the midwife in family planning.
  491. Role of the nurse and the midwife in the MCH/Family Planning Programme.
  492. The role of the pharmacist in family planning and prevention of venereal disease.
  493. The role of voluntary organizations in national family planning programs.
  494. Training for family planning health information system activities undertaken by the Population Centre.
  495. Training for population education and family planning activities.
  496. Training in contraception. (Letter to the editor)
  497. Training needs and strategy in support of community based family planning services.
  498. Training of paramedical personnel in family planning.
  499. Training-cum consultancy programme for management improvement in the Korean National Family Planning Programme: a draft plan for action.
  500. Treatment of diminished sexual response associated with the use of oral contraceptives. [Estudo sobre o tratamento das alteracoes da resposta sexual causadas pelo uso de anticoncepcionais.]

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.